The PRM assay confirmed the dynamic changes in SMIM1 and ANXA7 expression levels in RBCs during HCC tumorigenesis using clinical samples (Fig 4E and 4F and S3 and S4 Tables). Here, ANXA7 is linked to hepatocellular carcinoma.